Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia
Clinical trial NCT01003769 · TERMINATED
Trial details
- NCT number
- NCT01003769
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-09
- Primary completion
- 2018-12-14
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.